Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adnan Alseidi

Surgery Seattle, WA Medical Doctor

NPI 1821078379 CMS profile 82229

1100 9Th Ave, Seattle, WA 98101

Open in the dashboard

General payments

$239,850

211 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adnan Alseidi of Seattle, WA is reported in the CMS Open Payments database as having received $239,850 across 211 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,014 25
2024 General $19,605 18
2023 General $43,620 46
2022 General $28,535 28
2021 General $43,642 34
2020 General $37,231 19
2019 General $57,203 41

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adnan Alseidi
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Adnan Alseidi were reported at $10,014. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Adnan Alseidi Surgery median Middle half National median
2019 $57,203 $253 $82–$1,521 $163
2020 $37,231 $131 $40–$706 $114
2021 $43,642 $168 $50–$904 $132
2022 $28,535 $224 $76–$1,218 $149
2023 $43,620 $253 $82–$1,255 $160
2024 $19,605 $279 $90–$1,381 $164
2025 $10,014 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $160,683 92 payments
  2. Integra LifeSciences Corporation $22,798 18 payments
  3. Ethicon Inc. $18,868 14 payments
  4. Applied Medical Resources Corporation $11,647 18 payments
  5. BK Medical Holding Company Inc. $11,125 3 payments
  6. Ethicon US, LLC $9,793 37 payments
  7. Ethicon Endo-Surgery Inc. $1,683 1 payment
  8. Stryker Corporation $1,239 9 payments
  9. Intuitive Surgical, Inc. $1,127 11 payments
  10. Dilon Technologies, Inc. $347 2 payments
  11. Other $540 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $206,062 67 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,425 3 payments
  3. Travel and Lodging $10,259 35 payments
  4. Food and Beverage $7,849 104 payments
  5. Education $255 2 payments
Products named General payments · program years 2019–2025
  1. VISTASEAL $76,439 46 payments
  2. SURGICEL NU-KNIT $73,896 25 payments
  3. SURGIFLO Hemostatic Matrix $73,886 25 payments
  4. CERTUS 140 MICROWAVE ABLATION SYSTEM $36,094 18 payments
  5. CODMAN CERTAS $19,792 9 payments
  6. CUSA CLARITY $19,646 7 payments
  7. EVARREST $18,686 6 payments
  8. HARMONIC Product Family $18,218 15 payments
  9. ENSEAL Product Family $17,391 3 payments
  10. bk3000, bk3500 & bk5000 Ultrasound System $11,125 3 payments
  11. Other $29,562 152 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$48,337

Medicare's payments for the services billed

Medicare patients

46

Average age 70

Services billed

79

22 women, 24 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Ischemic heart disease 35%
Cancer 30%
Chronic kidney disease 28%
Arthritis 28%
Depression 24%
Osteoporosis 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

211 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record